tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Genmab A/S (GB:0MGB)
LSE:0MGB
UK Market
0MGB
Genmab A/S
Overview
Analyst Forecasts
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Genmab A/S (0MGB) Stock News & Sentiment

Compare
10 Followers
Genmab’s Promising Rina-S Developments Drive Buy Rating Amid Strong Initial Study Results
Premium
Ratings
Genmab’s Promising Rina-S Developments Drive Buy Rating Amid Strong Initial Study Results
14d ago
GMAB
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment
Premium
Ratings
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment
18d ago
GMAB
Genmab’s Strategic Forecast and Pipeline Potential Drive Buy Rating
Premium
Ratings
Genmab’s Strategic Forecast and Pipeline Potential Drive Buy Rating
21d ago
GMAB
Genmab’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Genmab’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
29d ago
GMAB
Genmab’s Strong Performance Overshadowed by Patent Expiration Concerns and Competitive Challenges
Premium
Ratings
Genmab’s Strong Performance Overshadowed by Patent Expiration Concerns and Competitive Challenges
1M ago
GMAB
Genmab’s Strong Market Position and Growth Potential Justifies Buy Rating
Premium
Ratings
Genmab’s Strong Market Position and Growth Potential Justifies Buy Rating
2M ago
GMAB
Genmab’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks
Premium
Ratings
Genmab’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Despite Minor Setbacks
2M ago
GMAB
More GB:0MGB News >

0MGB News on the Web

Morgan Stanley Keeps Their Hold Rating on Genmab (GMAB)
TipRanks News
Neutral
JPMorgan expects 'significant' underperformance of Genmab shares
The Fly
Neutral
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38
Yahoo Finance
Neutral
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Yahoo Finance UK
Neutral
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Yahoo Finance UK
Neutral
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab
Yahoo Finance UK
Neutral
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Yahoo Finance
Neutral
EPKINLY® Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
Yahoo Finance UK
Neutral

News Score - Last 7 Days

Neutral
GB:0MGB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0MGB’s Media Buzz Sentiment?
1 articles about GB:0MGB were published this week. In an average week, 1 articles are published.
    What is GB:0MGB’s weekly average amount of articles?
    In an average week, 1 articles about GB:0MGB are published.
      What is GB:0MGB’s News Sentiment?
      50% of articles about GB:0MGB were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CPRXCatalyst Pharma
        HQYHealthequity
        THCTenet Healthcare
        HIMSHims & Hers Health
        QGENQiagen
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing